- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Steven Seagal, DMX & Johnny Messner Are “Beyond the Law” in Wonderfilm’s Latest Theatrical Premiere
The Wonderfilm Media Corporation announces today the December 6th US theatrical premiere of its newest release, Beyond the Law.
The Wonderfilm Media Corporation (“Wonderfilm” or the “Company”) (TSXV:WNDR, OTCQB:WDRFF), a producer of high-quality feature films and episodic television with international appeal, announces today the December 6th US theatrical premiere of its newest release, Beyond the Law, starring Steven Seagal (Under Siege), DMX (Romeo Must Die) and Johnny Messner (Silencer, Weaponized).
Synopsis: Steven Seagal, DMX and Johnny Messner star in this action-packed thriller about one man’s quest for justice in a corrupt city. When a former detective learns of the murder of his estranged son, he ventures back to the darkened streets he once knew so well. Armed, dangerous and with nothing to lose, he must take on the ruthless local mob in his mission for revenge.
DMX, a best-selling rapper with four consecutive albums debuting at Number 1 on The Billboard 200 and Seagal starred together in the very successful 2001 action blockbuster Exit Wounds.
Produced by Timothy Woodward Jr. with Status Media and Entertainment, Micah E. Brandt and James Cullen Bressack (Bethany, Blood Craft) who produces and directs. Kirk Shaw and Dan Grodnik are co-executive producers for Wonderfilm.
Beyond the Law co-stars Zack Ward (Transformers), Chester Rushing (‘Stranger Things’), Randy Charach (Zombie Tidal Wave), Kim DeLonghi (the Handmaid’s Tale) and Bill Cobbs (Demolition Man).
Wonderfilm’s CEO, Kirk Shaw: “Beyond the Law is the fourth North American Wonderfilm theatrical release of 2019. It’s a big milestone for us, but next year we expect to double the number of movies released in theaters. Professionally, Beyond the Law was exciting since we were finally able to reunite Steven Seagal with DMX in a great action thriller. Fans have long been waiting for the return of the Exit Wounds on-screen action and chemistry. With a nod to the earlier movie’s success, DMX, Messner and Seagal aimed to give fans absolute action. The Director James Cullen Bressack deserves a lot credit, working tirelessly with the actors to create a vision for a dark world, offering a new take on the fighting style Seagal fans enjoy.”
Following its theatrical run, BEYOND THE LAW will be available on demand and Digital HD.
About Wonderfilm Media Corporation
Wonderfilm (OTCQB: WDRFF) (TSXV: WNDR) is a leading entertainment company with production offices in Los Angeles and corporate offices in Vancouver. The Company’s core business is producing market-driven independent feature films and quality television series for multi-platform global exploitation. Wonderfilm is a producer and distributor only for the projects disclosed. The legal ownership of movie productions is held in a special purpose legal entity held at arm’s length to the Company to facilitate for the qualification of various levels of domestic and foreign government tax credit incentives that are customary in the film and production business. For more information, visit the company’s website at www.Wonderfilm.com.
Neither the TSX Venture Exchange Inc. (“Exchange”) nor its regulation services provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this press release.
Cautionary Statements
This press release contains forward-looking statements as defined by applicable securities laws. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address expected future business and financial performance, and often contain words such as “anticipate,” “believe,” “plan,” “estimate,” “expect,” and “intend,” statements that an action or event “may,” “might,” “could,” “should,” or “will” be taken or occur, or other similar expressions. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond Wonderfilm’s control and Wonderfilm’s actual results could well differ materially from those stated or implied in forward-looking statements due to many various factors. Although Wonderfilm believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee that the events and circumstances reflected in the forward-looking statements will be achieved or occur. The timing of events and circumstances and actual results could differ materially from those projected in the forward-looking statements. Accordingly, one should not place undue reliance on forward-looking statements. All such statements reflect the date made only. Wonderfilm undertakes no obligation to update or publicly revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.